Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1967-5-2
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0022-2623
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
417-9
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:5960920-Amino Acids,
pubmed-meshheading:5960920-Animals,
pubmed-meshheading:5960920-Antineoplastic Agents,
pubmed-meshheading:5960920-Chemistry, Organic,
pubmed-meshheading:5960920-Mice,
pubmed-meshheading:5960920-Organic Chemistry Phenomena,
pubmed-meshheading:5960920-Pyrimidines
|
pubmed:year |
1966
|
pubmed:articleTitle |
v-Triazolo[4,5-d]pyrimidines. 3. N-(3-alkyl-5-amino-3H-v-triazolo[4,5-d]pyrimidin-7-yl)-amino acids.
|
pubmed:publicationType |
Journal Article
|